Korelacja odsetka hemoglobiny glikowanej z ciężkością choroby wieńcowej występująca u młodych osób niezależnie od tradycyjnych czynników ryzyka by Ayhan, S. Selim et al.
367
Prace oryginalne/original PaPers
Endokrynologia Polska/Polish Journal of Endocrinology
Tom/Volume 63; Numer/Number 5/2012
ISSN 0423–104X
Aytekin Alcelik, Abant Izzet Baysal University, Medical Faculty, Department of Internal Medicine, Bolu, Turkey, tel.: +90 374 253 4618,  
fax: +90 374 253 4615, e-mail: aytekinalcelik@yahoo.com
Glycated haemoglobin is correlated with the severity  
of coronary artery disease independently of traditional  
risk factors in young patients
Korelacja odsetka hemoglobiny glikowanej z ciężkością choroby wieńcowej 
występująca u młodych osób niezależnie od tradycyjnych czynników ryzyka
S. Selim Ayhan1, Mehmet Tosun2, Serkan Ozturk1, Aytekin Alcelik3, Mehmet Fatih Ozlu1, Alim Erdem1, 
Kemalettin Erdem4, Fatma Hizal Erdem5, Mehmet Yazici1
1Department of Cardiology, Izzet Baysal Medical Faculty, Bolu, Turkey 
2Department of Biochemistry, Izzet Baysal Medical Faculty, Bolu, Turkey 
3Department of Internal Medicine, Izzet Baysal Medical Faculty, Bolu, Turkey 
4Department of Cardiovascular Surgery, Izzet Baysal Medical Faculty, Bolu, Turkey 
5Department of Cardiology, Numune Hospital, Sivas, Turkey
Abstract
Introduction: In this study, we aimed to investigate the relationship between glycated haemoglobin (HbA1c) levels and the severity of 
coronary artery disease (CAD) in < 40 years old patients.
Material and methods: The study population consisted of 211 premature coronary atherosclerotic patients (pCAP) (aged 36.4 ± 2.5 years) 
and 160 control subjects (36.4 ± 2.4 years). The severity of CAD was evaluated by the Gensini scoring system. HbA1c levels and the other 
basic biochemical parameters were analysed, and relations with severity of CAD were evaluated.
Results: There were statistically significant differences in serum HbA1c levels between the two groups (pCAP = 6.1 ± 1.8%, control 
= 4.7 ± 1.2%, p < 0.001). HbA1c levels significantly positively correlated with the Gensini score in pCAP (r = 0.662, p < 0.001). In linear 
multivariate regression analysis (including age, sex, HbA1c, smoking, diabetes mellitus and hypertension as dependent parameters), only 
HbA1c was found to be an independent risk factor for the presence of severe CAD (Beta = 0.374, p < 0.001). In ROC curve analysis, the 
optimal cut-off value of HbA1c to predict severe CAD was 6.52%, with 74.4% sensitivity and 75.1% specificity (area under the curve 0.781, 
95% confidence interval 0.661 to 0.901, p < 0.001).
Conclusions: HbA1c levels were found to be correlated with the Gensini score in pCAP with and without diabetes. In this respect, glucose 
metabolism abnormalities, indicated by HbA1c, may play an important role in premature CAD. (Endokrynol Pol 2012; 63 (5): 367–371)
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Streszczenie
Wstęp: Niniejsze badanie przeprowadzono w celu oceny zależności między odsetkiem hemoglobiny glikowanej (HbA1c) a ciężkością 
choroby wieńcowej (CAD) u chorych w wieku < 40 lat.
Materiał i metody: Badana populacja składała się z 211 chorych z przedwczesną miażdżycą tętnic wieńcowych (pCAP) (w wieku 36,4 ± 2,5 
roku) i 160 osób stanowiących grupę kontrolną (36,4 ± 2,4 roku). Ciężkość CAD określano na podstawie wartości wskaźnika Gensiniego. 
Przeanalizowano odsetek HbA1c oraz inne wyjściowe parametry biochemiczne i oceniono ich zależności z ciężkością CAD.
Wyniki: Stwierdzono statystycznie istotne różnice między grupami w zakresie stężeń HbA1c w surowicy (pCAP = 6,1 ± 1,8%, grupa 
kontrolna = 4,7 ± 1,2%; p < 0,001). Wartości HbA1c były istotnie skorelowane z wartościami wskaźnika Gensiniego u chorych z pCAP 
(r = 0,662; p < 0,001). W wieloczynnikowej analizie regresji liniowej (w której uwzględniono wiek, płeć, stężenie HbA1c, palenie tytoniu, 
cukrzycę i nadciśnienie tętnicze jako zmienne zależne) jedynie stężenie HbA1c okazało się niezależnym czynnikiem ryzyka wskazującym 
na występowanie ciężkiej CAD (Beta = 0,374; p < 0,001). Jak wykazano w analizie krzywych ROC, optymalny punkt odcięcia wartości 
HbA1c pozwalający prognozować ciężką CAD wynosi 6,52%, przy czułości metody 74,4% i swoistości 75,1% (pole pod krzywą 0,781, 
95-proc. przedział ufności 0,661–0,901; p < 0,001).
Wnioski: U osób z pCAP, zarówno chorych na cukrzycę, jak i bez tej choroby, stwierdzono korelacje między wartościami HbA1c i wskaź-
nikiem Gensiniego. Jak wynika z powyższych obserwacji, zaburzenia metabolizmu glukozy, których wyznacznikiem jest odsetek HbA1c, 
mogą odgrywać ważną rolę w rozwoju przedwczesnej CAD. (Endokrynol Pol 2012; 63 (5): 367–371)
Słowa kluczowe: hemoglobina glikowana, przedwczesna choroba wieńcowa, wskaźnik Gensiniego
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Introduction
Although the age limits are not defined, the term 
premature or early atherosclerosis is often used to de-
scribe atherosclerosis that develops before 40–50 years 
of age [1–3]. The main known risk factors for the de-
velopment of early atherosclerosis are diabetes mellitus 
(DM), dyslipidaemia, cigarette smoking, and a family 
history [4–6]. Chronic hyperglycaemia has also been 
identified as a risk factor for diabetic complications 
leading to accelerated atherosclerosis [7]. Some studies 
have shown that elevated plasma glucose levels nega-
tively affect the severity of atherosclerosis and cardiac 
remodelling in all populations, regardless of the pres-
ence of DM [4, 8–10].
Glycated haemoglobin (HbA1c) has been used 
to monitor the plasma glycaemic status of diabetic 
patients, and is currently used to diagnose DM [11]. 
Studies show that HbA1c is more useful than fasting 
plasma glucose levels for assessing coronary artery 
disease (CAD) risk and mortality [12]. HbA1c levels in-
dicate both short- and long-term increased mortality 
risks in patients with CAD [13]. There is a significant 
relationship between HbA1c levels and atherosclerosis, 
even in non-diabetic populations and even in people 
with normal HbA1c levels [12, 14]. Some studies have 
found a relationship between the severity of CAD 
and HbA1c levels in patients with acute coronary 
syndrome [13–15].
To the best of our knowledge, however, no study 
has evaluated the association between HbA1c levels 
and the severity of CAD in patients with premature 
atherosclerosis.
Therefore, this study investigated the relationship 
between HbA1c levels and the severity of premature 
coronary artery disease.
Material and methods
Study population
This study was designed retrospectively: 211 premature 
coronary atherosclerotic patients (pCAP) (36.4 ± 2.5 years) 
and 160 control subjects (36.4 ± 2.4 years) selected from 
patients who had undergone coronary angiography 
at Abant Izzet Baysal University School of Medicine 
Hospital and Sivas Numune Hospital between January 
2010 and December 2011, were included in the study. 
The control group consisted of age-matched and sex-
matched individuals who were selected in a consecutive 
manner from the catheterized patients during the same 
study period and who proved to have normal coronary 
angiograms. Demographic parameters, risk factors for 
atherosclerosis and past medical history were recorded 
for all patients.
Hypertension (HT) was considered to be present if 
the systolic pressure was greater than 140 mm Hg and/or 
diastolic pressure was greater than 90 mm Hg. Diabetes 
mellitus was defined as having fasting blood glucose 
higher than 126 mg/dL or second hour postprandial 
blood glucose higher than 200 mg/dL, together with pre-
viously diagnosed patients using antidiabetic therapy. 
Cigarette smoking was defined as the use of more than 
ten cigarettes a day at the time of diagnosis. Subjects 
with a history of percutaneous transluminal coronary 
angioplasty, acute myocardial infarction, alcohol intake 
more than 30 g/day, having transaminases exceeding 
three times the upper reference range, antioxidant drug 
use, renal or hepatic insufficiency and type 1 DM were 
excluded from the study. The indication for coronary 
angiography was either the presence of typical angina 
or positive or equivocal results of noninvasive screening 
tests for myocardial ischaemia, in all groups. The study 
protocol was approved by the local ethics committee.
Coronary angiography
Coronary angiography was performed by Judkin’s 
technique. Two experienced cardiologists analysed the 
angiographic results. All angiograms were evaluated by 
Gensini scoring system in terms of severity of coronary 
stenosis [16]. A score of 1 indicates 1–25%, 2 indicates 
26–50%, 4 indicates 51–71%, 8 indicates 76–90%, and 
16 indicates 91–99% narrowing in the lumen of coronary 
artery; a score of 32 indicates a totally occluded artery. 
The Gensini score is multiplied by a factor which is as-
sociated with the functional importance of the coronary 
artery depending on the myocardial region supplied 
by that coronary segment. This factor is 5 for left main 
system lesions, 2.5 for proximal left anterior descending 
artery and proximal circumflex artery lesions, 1 for distal 
left anterior descending artery, mid/distal circumflex 
artery and right coronary artery lesions, and 0.5 for le-
sions in any other artery branches. Angiography results 
were divided into mild CAD (Gensini score ≤ 20), and 
severe CAD (Gensini score > 20).
Biochemical investigations
Blood samples were obtained after overnight fasting. 
HbA1c measurement was made using the immunoturbi-
dimetry method. Analysis of transaminases, creatinine, 
total cholesterol (TC), triglycerides (TG), high-density 
lipoprotein cholesterol (HDL-C), low-density lipopro-
tein cholesterol (LDL-C), gamma-glutamyltransferase 
(GGT), haemoglobin, and glucose were made using 
standard methods.
Statistical analysis
All statistical analyses were performed using the SPSS 
software package 15.0 (SPSS Inc, Chicago, IL, USA). 
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Data is presented as frequencies and percentages for 
categorical variables and mean ± SD or median for 
continuous variables, unless otherwise indicated. The 
groups were compared using the Student’s t-test for 
the continuous variables and the chi-square test for the 
categorical variables. Correlation between continuous 
variables was determined by Pearson correlation coef-
ficients. Linear multivariate logistic regression analysis 
was performed to identify the independent predictors 
of severe CAD. A value of p < 0.05 was considered 
statistically significant.
Results
The study population consisted of 211 premature coro-
nary atherosclerotic patients (pCAP) and 160 controls. 
The main clinical characteristics of the study popula-
tions are shown in Table I. Laboratory characteristics 
of patients were not statistically different. There were 
strong statistically significant differences in serum 
HbA1c levels between the two groups (pCAP = 6.1 ± 
± 1.8%, control = 4.7 ± 1.2%, p < 0.001). There were 
mildly statistically significant differences between the 
groups with respect to DM (p = 0.05). HbA1c levels 
significantly positively correlated with the Gensini 
score in pCAP (r = 0.662, p < 0.001) (Fig. 1).
In the whole study population, 170 patients had 
DM (106 patients premature coronary atherosclerotic 
patients, 64 control patients). HbA1c levels were sig-
nificantly higher in diabetic pCAP (7.1 ± 1.4%, 5.3 ± 
± 1.4%, p < 0.001). There were no significant differ-
ences in sex, HT, family history, creatinine levels, or 
Table I. Clinical and laboratory parameters of the study groups
Tabela I. Parametry kliniczne i laboratoryjne w badanych grupach
Parameter CAD group 
(n = 211)
Control group 
(n = 160)
p value
Male (%) 67.8 62.5 0.291
Age (years) 36.4 ± 2.5 36.4 ± 2.4 0.997
Hypertension (%) 37.0 29.4 0.126
Diabetes mellitus (%) 50.2 40.0 0.050
Smokers (%) 54.0 53.8 0.958
HbA1c (%) 6.1 ± 1.8 4.7 ± 1.2 0.001
Statin use (%) 6.4 5.9 0.180
Haemoglobin [g/dL] 13.2 ± 1.5 13.24 ± 1.32 0.832
Total cholesterol [mg/dL] 177.5 ± 33.7 178.4 ± 34.5 0.346
LDL cholesterol [mg/dL] 105.4 ± 24.2 103.0 ± 24.6 0.218
HDL cholesterol [mg/dL] 44.2 ± 11.4 44.3 ± 10.6 0.829
Triglycerides [mg/dL] 129.2 ± 33.8 132.3 ± 34.7 0.812
Creatinine [mg/dL] 0.8 ± 0.1 0.8 ± 0.1 0.244
AST [U/L] 22.5 ± 6.6 21.9 ± 6.4 0.852
ALT [U/L] 23.0 ± 5.6 22.8 ± 5.8 0.813
GGT [U/L] 37.8 ± 13.0 36.8 ± 9.0 0.418
CAD — coronary artery disease; LDL — low-density lipoprotein; HDL — high-density lipoprotein; ALT — alanine aminotransferase; AST — aspartate 
aminotransferase; GGT — g-glutamyl transferase
Figure 1. Correlation of HbA1c levels and Gensini score in Group 1
Rycina 1. Korelacje między odsetkiem HbA1c i wskaźnikiem 
Gensiniego w grupie 1
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smoking between diabetic subgroups except age (36.6 
± 5.3, 35.2 ± 5.1, p = 0.042).
In subgroup analyses of pCAP, 97 patients had mild 
CAD (Gensini score ≤ 20), and 114 patients had severe 
CAD (Gensini score > 20). There were no significant 
differences in age, HT, family history, creatinine levels, 
or smoking between mild and severe CAD, except 
DM. HbA1c levels were statistically different between 
groups (7.0 ± 1.4%, 4.7 ± 1.4%, p < 0.001). HbA1c levels 
significantly positively correlated with the Gensini 
score in mild CAD and severe CAD patients (r = 0.347, 
p = 0.002, r = 0.377, p < 0.001, respectively).
In linear multivariate regression analysis (includ-
ing age, sex, HbA1c levels, smoking, DM and hyperten-
sion as dependent parameters), only HbA1c was found 
to be an independent risk factor for the presence of 
severe CAD (Beta = 0.374, p < 0.001).
In ROC curve analysis, the optimal cut-off value of 
HbA1c to predict severe CAD was 6.52%, with 74.4% 
sensitivity and 75.1% specificity (area under the curve 
0.781, 95% confidence interval 0.661 to 0.901, p < 0.001; 
Fig. 2).
Discussion
Glucose metabolism disorders play an important role 
in the pathophysiology of atherosclerosis [17]. HbA1c is 
usually used to evaluate the effectiveness of diabetes 
therapy. Recently, it has also been used to diagnose 
DM [18]. In this study, we investigated the relation-
ship between HbA1c levels and the severity of CAD in 
patients younger than 40 years. Our main finding was 
a significant correlation between the Gensini score 
and HbA1c levels in premature CAD patients with or 
without DM. In addition, the HbA1c levels were the 
only independent predictor of severe CAD (Gensini 
score > 20). To the best of our knowledge, the relation-
ship between HbA1c levels and the severity of CAD in 
premature coronary atherosclerotic patients has not 
previously been reported.
Atherosclerosis affects the coronary arteries of dia-
betic patients more severely and diffusely than those 
of non-diabetics [8–10]. Berry et al. found that fasting 
blood glucose, HbA1c, and presence of diabetes were as-
sociated with the severity and progression of coronary 
atherosclerosis. They concluded that better glycaemic 
control favourably influences CAD in patients with 
abnormal glucose tolerance or diabetes [8]. Ravipati et 
al. showed that the HbA1c level increased significantly 
with the number of arteries with CAD in diabetics [9]. 
Similarly, we found that HbA1c levels were correlated 
with the severity of coronary atherosclerosis in both 
diabetic and non-diabetic patients.
In a recent trial, Selvin et al. reported that HbA1c 
was a marker of cardiovascular risk in non-diabetics 
[12]. They followed 11,092 patients to identify adults at 
risk for diabetes or cardiovascular disease. HbA1c was 
more strongly associated with the risks of cardiovascular 
disease and death from any cause than fasting glucose 
levels. They also reported that HbA1c was equally as-
sociated with the diabetes risk compared to the fast-
ing glucose levels. We did not assess the prognostic 
importance of HbA1c in our study, and evaluated only 
patients younger than 40 years. Their study revealed 
the importance of glucose metabolism abnormalities 
in the atherosclerotic process, even in non-diabetics. 
Similarly, we found a correlation between the severity of 
coronary atherosclerosis and HbA1c levels in premature 
CAD patients, regardless of the presence of DM.
In a recent meta-analysis, Liu et al. reported that 
elevated HbA1c levels were an independent risk factor 
for mortality [13]. In subgroup analyses, they found that 
an elevated HbA1c level predicted a higher mortality 
risk in non-diabetics, while they did not detect an in-
creased mortality risk in diabetics. Two reasons for their 
conflicting findings between patients with and without 
diabetes were drug use and risk factor control. In other 
words, diabetic patients were tightly controlled in terms 
of risk factors such as dyslipidaemia and hypertension. 
In contrast, we evaluated premature CAD patients in 
a cross-sectional manner. We also suggest that HbA1c 
has a high sensitivity and specificity for predicting 
severe CAD.
Figure 2. ROC curve analysis, the optimal cut-off value of 
HbA1c to predict severe CAD
Rycina 2. Analiza krzywych ROC, optymalne punkty odcięcia 
wartości HbA1c do prognozowania ciężkiej CAD
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In another study, Mi et al. evaluated glycaemic variabil-
ity and HbA1c as risk factors for CAD in newly diagnosed 
diabetics [19]. They found that HbA1c and glycaemic vari-
ability were associated with the presence and severity of 
CAD in patients with newly-diagnosed DM. They also 
evaluated CAD severity using the Gensini score, similarly 
to us. However, their population was older than ours, as 
we only evaluated patients younger than 40 years.
In conclusion, HbA1c levels predict the severity 
of coronary atherosclerosis in patients younger than 
40 years. In this respect, our findings demonstrate the 
importance of maintaining an optimal HbA1c level for 
increased cardiovascular atherosclerosis, not only in 
diabetics, but also in non-diabetics.
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